AVANT IMMUNOTHERAPEUTICS INC (AVAN) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 18 transactions totaling $15.0M, demonstrating a bullish sentiment with $5.1M in net insider flow. The most recent transaction on Oct 1, 2020 involved a purchase of 1,000,000 shares valued at $10.0M.
No significant insider buying has been recorded for AVAN in the recent period.
No significant insider selling has been recorded for AVAN in the recent period.
Based on recent SEC filings, insider sentiment for AVAN is bullish with an Insider Alignment Score of 67/100 and a net flow of $5.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AVANT IMMUNOTHERAPEUTICS INC (AVAN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AVAN stock, having executed 18 transactions in the past 90 days. The most active insider is Roberto Mignone (Executive), who has made 1 transactions totaling $10.0M.
Get notified when executives and directors at AVAN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 1, 2020 | Mignone Roberto | Executive | Purchase | 1,000,000 | $10.00 | $10.0M | Large |
| Sep 10, 2008 | R. Parekh Rajesh | Executive | Sale | 2,178 | $11.00 | $24.0K | |
| Sep 9, 2008 | R. Parekh Rajesh | Executive | Sale | 25,770 | $11.05 | $284.8K | |
| Sep 8, 2008 | R. Parekh Rajesh | Executive | Sale | 28,275 | $11.37 | $321.5K | |
| Jun 23, 2008 | Medarex Inc | Executive | Sale | 351,691 | $12.35 | $4.3M | Large |
| Apr 7, 2008 | Ltd Lorantis Holdings | Executive | Other | 2,811,147 | $N/A | $0 | |
| Jan 2, 2008 | Keilani Taha | Executive | Small Acquisition | 500 | $0.43 | $215 | |
| Jan 2, 2008 | R. Freeman Paula | Executive | Small Acquisition | 500 | $0.43 | $215 | |
| Jul 2, 2007 | S. Ryan Una | Executive | Small Acquisition | 500 | $0.71 | $355 | |
| Jul 2, 2007 | W. Catlin Avery | Executive | Small Acquisition | 500 | $0.71 | $355 | |
| Aug 16, 2006 | W. Catlin Avery | Executive | Purchase | 5,000 | $1.35 | $6.8K | |
| Aug 16, 2006 | S. Ryan Una | Executive | Purchase | 30,300 | $1.36 | $41.2K | |
| Jul 3, 2006 | W. Catlin Avery | Executive | Small Acquisition | 500 | $1.37 | $685 | |
| Jul 3, 2006 | Keilani Taha | Executive | Small Acquisition | 500 | $1.37 | $685 | |
| Jul 3, 2006 | S. Ryan Una | Executive | Small Acquisition | 500 | $1.37 | $685 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 3 | $10.0M | 66.8% |
Sale(S) | 4 | $5.0M | 33.1% |
Exercise(M) | 1 | $4.9K | 0.0% |
Small Acquisition(L) | 9 | $4.2K | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at AVANT IMMUNOTHERAPEUTICS INC are accumulating shares at an accelerated pace. With 9 insiders making 18 transactions totaling $10.0M in purchases versus $5.0M in sales, the net buying activity of $5.1M signals strong executive confidence. Roberto Mignone (Executive) leads the buying activity with $10.0M in transactions across all time.